Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy: Feasibility Study (CARTePRO)

NCT05354973 is registered in ClinicalTrials.gov with Stiftung Swiss Tumor Institute as lead sponsor.

NCT NCT05354973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy: Feasibility Study (CARTePRO)
Lead sponsor
Stiftung Swiss Tumor Institute
Phase
Observational
Overall status
Unknown status
Start date
March 21, 2022
Completion date
April 30, 2025
Enrollment
11 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

car t-cell therapy, patient reported outcome measures